Drug Shortage Report for APO-LITHIUM CARBONATE
Report ID | 49367 |
Drug Identification Number | 02242838 |
Brand name | APO-LITHIUM CARBONATE |
Common or Proper name | LITHIUM CARBONATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 1000 BTL |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-05-14 |
Estimated end date | Unknown |
Actual end date | 2018-09-10 |
Shortage status | Resolved |
Updated date | 2018-09-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-09-11 | English | Compare |
v10 | 2018-09-10 | French | Compare |
v9 | 2018-09-10 | English | Compare |
v8 | 2018-08-01 | French | Compare |
v7 | 2018-08-01 | English | Compare |
v6 | 2018-05-29 | French | Compare |
v5 | 2018-05-29 | English | Compare |
v4 | 2018-05-22 | French | Compare |
v3 | 2018-05-22 | English | Compare |
v2 | 2018-05-15 | French | Compare |
v1 | 2018-05-15 | English | Compare |
Showing 1 to 11 of 11